Follicle-stimulating hormone, interleukin-1, and bone density in adult women

被引:52
作者
Cannon, Joseph G. [1 ]
Cortez-Cooper, Miriam [1 ]
Meaders, Eric [1 ]
Stallings, Judith [1 ]
Haddow, Sara [1 ]
Kraj, Barbara [1 ]
Sloan, Gloria [1 ]
Mulloy, Anthony [2 ]
机构
[1] Med Coll Georgia, Sch Allied Hlth Sci, Augusta, GA 30912 USA
[2] Med Coll Georgia, Sch Med, Augusta, GA 30912 USA
关键词
leptin; inhibin; physical activity; TUMOR-NECROSIS-FACTOR; RECEPTOR ANTAGONIST; MINERAL DENSITY; MENOPAUSAL TRANSITION; FSH RECEPTOR; POSTMENOPAUSAL WOMEN; LUTEINIZING-HORMONE; PERIPHERAL-BLOOD; HUMAN MONOCYTES; SERUM LEPTIN;
D O I
10.1152/ajpregu.00728.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cannon JG, Cortez-Cooper M, Meaders E, Stallings J, Haddow S, Kraj B, Sloan G, Mulloy A. Follicle-stimulating hormone, interleukin-1, and bone density in adult women. Am J Physiol Regul Integr Comp Physiol 298: R790-R798, 2010. First published December 30, 2009; doi:10.1152/ajpregu.00728.2009.-Recent studies have indicated that follicle-stimulating hormone (FSH) promotes bone loss. The present study tested the hypothesis that FSH enhances the activity of bone-resorbing cytokines [interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, and IL-6], either by inducing their secretion or by altering their receptor expression. Thirty-six women between the ages of 20 and 50 were assessed for bone mineral density (BMD), reproductive hormone, cytokine ligand and soluble receptor concentrations, and surface expression of cytokine receptors on monocytes. In addition, isolated mononuclear cells were incubated in vitro with exogenous FSH. Univariate regression analyses indicated that BMD was inversely related to serum FSH (r = -0.29 to -0.51, P = 0.03-0.001, depending upon the skeletal site). Physical activity and body composition were also identified as significant factors by multiple regressions. Exogenous FSH induced isolated cells to secrete IL-1 beta, TNF-alpha, and IL-6 in proportion to the surface expression of FSH receptors on the monocytes. Endogenous (serum) FSH concentrations correlated with the circulating concentrations of these cytokines. None of these individual cytokines was related to BMD, but the IL-1 beta to IL-1 receptor antagonist (IL-1Ra) ratio was inversely related to BMD (r = -0.53, P = 0.002) in all but the most physically active women, who had significantly lower expression of IL-1 type I receptors relative to type II (decoy receptors, P = 0.01). Physical activity also correlated positively with secretion of inhibitory soluble IL-1 receptors (r = 0.53, P = 0.003). Moreover, IL-1Ra correlated strongly with percent body fat (r = 0.66, P < 0.0001). These results indicate that BMD is related to FSH concentration, physical activity, and body composition. Although each of these factors likely has direct effects on bone, the present study suggests that each may also influence BMD by modulating the activity of the osteoresorptive cytokine IL-1 beta
引用
收藏
页码:R790 / R798
页数:9
相关论文
共 49 条
[1]   Cytokines and bone loss in a 5-year longitudinal study - Hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study [J].
Abrahamsen, B ;
Bonnevie-Nielsen, V ;
Ebbesen, EN ;
Gram, J ;
Beck-Nielsen, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1545-1554
[2]  
Arend WP, 2002, J RHEUMATOL, V29, P16
[3]   SUBSET-SPECIFIC EFFECTS OF SEX-HORMONES AND PITUITARY GONADOTROPINS ON HUMAN LYMPHOCYTE-PROLIFERATION INVITRO [J].
ATHREYA, BH ;
PLETCHER, J ;
ZULIAN, F ;
WEINER, DB ;
WILLIAMS, WV .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 66 (03) :201-211
[4]   RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone [J].
Atkins, Gerald J. ;
Kostakis, Panagiota ;
Vincent, Cristina ;
Farrugia, Amanda N. ;
Houchins, Jeffrey P. ;
Findlay, David M. ;
Evdokiou, Andreas ;
Zannettino, Andrew C. W. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (09) :1339-1349
[5]   Serum leptin level is a predictor of bone mineral density in postmenopausal women [J].
Blain, H ;
Vuillemin, A ;
Guillemin, F ;
Durant, R ;
Hanesse, B ;
De Talance, N ;
Doucet, B ;
Jeandel, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1030-1035
[6]   Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women [J].
Burger, HG ;
Dudley, EC ;
Hopper, JL ;
Groome, N ;
Guthrie, JR ;
Green, A ;
Dennerstein, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4025-4030
[7]  
Cannon JG, 2006, FASEB J, V20, pA1285
[8]   Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome [J].
Cannon, JG ;
Angel, JB ;
Abad, LW ;
Vannier, E ;
Mileno, MD ;
Fagioli, L ;
Wolff, SM ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) :253-261
[9]   International physical activity questionnaire:: 12-country reliability and validity [J].
Craig, CL ;
Marshall, AL ;
Sjöström, M ;
Bauman, AE ;
Booth, ML ;
Ainsworth, BE ;
Pratt, M ;
Ekelund, U ;
Yngve, A ;
Sallis, JF ;
Oja, P .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (08) :1381-1395
[10]   Immunological and Inflammatory Functions of the Interleukin-1 Family [J].
Dinarello, Charles A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :519-550